By Charlotte Kuperwasser at Brownstone dot org.

After witnessing, and continuing to witness, the reaction to emerging information about the early cancer signal related to Covid-19 vaccination or infection, I recalled the historical timelines of other early cancer signals.

What became immediately clear is that this moment is not unique. For more than a century, society has repeatedly failed to act on early warnings linking environmental, occupational, pharmaceutical, and consumer exposures to cancer. These failures have often been framed as the inevitable cost of scientific uncertainty. But that explanation no longer holds.

Today, we are not limited by analytic tools, epidemiology, or biology. In the modern era, the dominant causes of delay are no longer scientific. They are structural, regulatory, economic, and epistemic (relating to knowledge). And the cost of those delays is increasingly visible in the form of rising early-onset cancers, hormone-sensitive malignancies, exposure-associated cancers, and chronic disease patterns that no longer fit classical models of carcinogenesis. And most recently, in the case of Covid-19 vaccinations, reports of unusually rapid tumor progression.

A Century-Long Pattern We Refuse to Learn from

If we look honestly at the history between cancer signal to acceptance and prevention, a striking pattern emerges.

Before the 1950s, long delays between exposure signals and public health action were often unavoidable. The scientific infrastructure simply didn't exist. Chimney soot took more than 60 years to be accepted as carcinogenic, and over 150 years to understand mechanistically, because there was no exposure science, no molecular biology, and no population-level analytic framework. Oncogenic viruses faced decades of resistance because the idea that infections could cause cancer violated prevailing dogma. Helicobacter pylori infection languished for nearly a century under the assumption that stomach ulcers were caused by stress, not bacteria. These delays were tragic, but they reflected real scientific constraints.

After the 1950s, however, those constraints largely disappeared. Cancer registries expanded. Epidemiology matured. Exposure assessment improved. Molecular tools exploded. Yet delays persisted, and in many cases, lengthened. It took ~40 yrs to accept the cigarettes signal and ~60-80 years until regulatory action. Risk was evident decades before meaningful regulation, delayed by industry interference, data distortion, and journal gatekeeping. Asbestos also took ~55-60yrs to accept signal and ~70-80 yrs until regulatory action.

Acceptance and regulation lagged despite overwhelming evidence, slowed by economic and political pressure. The synthetic estrogen DES took ~33 yrs to accept signal, and while regulatory reform was immediate, it was not removed from the market and even after clear signals of harm, clinical inertia delayed action. Other environmental exposures (DDT, PCBs, BPA, PFAS, glyphosate) each followed the same arc: early signals, prolonged controversy, regulatory paralysis, maybe eventual acknowledgment long after widespread exposure. (DTT took ~30–40 yrs, PCBs ~30-40yrs, PFAS: >60yrs, glyphosate: >30 yrs and still ongoing). In all these cases, the delays were not failures of detection; they were failures of response.

The Mechanism Trap

A new bottleneck has quietly taken hold in modern science: mechanism has become a prerequisite for concern and action.

Today, strong exposure–outcome signals are often dismissed unless accompanied by a fully articulated causal pathway. This has several consequences. NIH funding overwhelmingly favors hypothesis-driven mechanistic work over signal confirmation. Independent replication of early epidemiologic signals is rare and underfunded. Observations that don't align with dominant paradigms (non-genotoxic mechanisms, mixtures, immune modulation, developmental timing) stall indefinitely. And so now, we have created a paradox: we demand mechan...